US Stock MarketDetailed Quotes
VYNE VYNE Therapeutics
- 2.8900
- 0.00000.00%
Trading Nov 26 16:00 ET
42.63MMarket Cap0.85P/E (TTM)
0.0000High0.0000Low74Volume2.9000Open2.8900Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)14.75MShares3.620052wk High0.67P/B31.21MFloat Cap1.570052wk Low--Dividend TTM10.80MShs Float2869.9200Historical High--Div YieldTTM0.00%Amplitude1.5700Historical Low0.0000Avg Price1Lot Size
VYNE Therapeutics Key Stats
EPS
According to the latest financial report of VYNE Therapeutics, the latest earnings per share (TTM) for the company is -0.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about VYNE Therapeutics's free cash flow? The latest report shows it as -8.51M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of VYNE Therapeutics shows that the company's current ratio is 5.81, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of VYNE Therapeutics, the quick ratio is 5.54, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of VYNE Therapeutics? The latest ROE figure is -17.57%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of VYNE Therapeutics, the total asset return on investment (ROA) is -14.93%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check VYNE Therapeutics's latest financial report to see how their gross margin is doing - currently at 87.54%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of VYNE Therapeutics, the net profit margin is -10.05K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data